drugset / Trial / NCT00745498

Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy

NCT00745498

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effect of pre- and intra-operative bevacizumab injection on postoperative vitreous hemorrhage after diabetic vitrectomy.

Timeline

Start
2008-06
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 1.25 mg Intravitreal